March 29, 2013 – Boehringer Ingelheim, Eli Lilly submit New Drug Application (NDA) for empagliflozin.
Mar 2013 – Application submitted
Announcement Date: March 29, 2013
March 29, 2013 – Boehringer Ingelheim, Eli Lilly submit New Drug Application (NDA) for empagliflozin.